Publication

Article

BioPharm International Sponsored eBooks

BioPharm International Sponsored eBooks-07-20-2022
Volume
Issue 2

Predicting Viral Clearance Through the Use of Non-Infectious Virus Particle Surrogates

Author(s):

Cygnus Technologies

Articles in this issue
Predicting Viral Clearance Through the Use of Non-Infectious Virus Particle Surrogates

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!
Related Content
Site Logo
August 26th 2025

Benefits of Wireless Continuous Monitoring Systems

Mesa Labs
Site Logo
August 26th 2025

Bill Hartzell, SVP, Manufacturing and Bioservices, on Emergent’s Unique Strategic Manufacturing Partnerships and the Storied History of Our Winnipeg Site

Emergent
Site Logo
August 26th 2025

A Strategic Manufacturing Partner

Emergent
Site Logo
August 26th 2025

Decentralized Trials: The Value of Direct-to-Patient & Pharmacy-Led Solutions

Site Logo
August 26th 2025

Demand-Led Clinical Supply Model for Program-level Product Pooling in Global Decentralized Study

Site Logo
August 26th 2025

Tech Transfer and Scale-Up of E. coli Fermentation: BIOVECTRA & ABEC Collaboration

© 2025 MJH Life Sciences

All rights reserved.